Concepedia

A. Oden-Gangloff

AO

Statistics

Publications

3

Citations

202

H-Index

3

Active since

2009

Affiliations

Université de Rouen Normandie(Current)

Centre Hospitalier Universitaire de Rouen

Inserm

Roche (France)

Centre Hospitalier Universitaire de Reims

A. Oden-Gangloff is an author at Université de Rouen Normandie specializing in oncology, medicine, and chemotherapy.

Publications per year

2009–2018

3

Publications

3

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

A. Oden-Gangloff, F. Di Fiore, Frédéric Bibeau et al. · British Journal of Cancer · 2009 · 84 citations · Full text

, , +17

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Thomas Aparicio, Olivier Bouché, E. Maillard et al. · Annals of Oncology · 2017 · 79 citations · Full text

, , +12

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer

Thomas Aparicio, Olivier Bouché, E. François et al. · European Journal of Cancer · 2018 · 39 citations

, , +11

1–3 of 3